FDBusiness.com

Extended use of Glavonoid™

 Breaking News
  • Florette Further Expands its UK Business In line with its strategy to be a major player within the UK fresh produce category, Florette UK & Ireland (part of the French Agrial group) has acquired the Wigan site of MyFresh Prepared Produce, a producer of a wide range of salad and vegetable products. MyFresh, Wigan, which employs almost 300 people and was [...]...
  • FrieslandCampina Simplifies its Organisation Royal FrieslandCampina intends to simplify its organizational structure into four to be set up global business groups – Consumer Dairy, Specialised Nutrition, Ingredients and Basic Dairy. A less complex structure will enable FrieslandCampina to more decisively respond to the market developments and to innovate better with respect to strategic priorities. The objective of the new [...]...
  • Heineken’s Acquisition of Punch is Cleared The Competition and Markets Authority (CMA) has accepted proposals by Heineken to resolve concerns over its £402.7 million acquisition of Punch Taverns, one of the UK’s largest leased pub companies, with a portfolio of more than 3,500 pubs nationwide. In June, the CMA said that Heineken’s proposed purchase of part of the Punch Taverns estate [...]...
  • Changing Consumer Tastes Drive Long-term Global Sugar Market Slowdown The consumers’ shift away from sugar consumption is an important driver behind significant changes in the food and beverage industry. These changes will have long-term ramifications, including a likely slowdown in the worldwide sugar market, according to the latest report of Rabobank ‘Sweetness and Lite’. A combination of changing preferences, product reformulations and government pressure have [...]...
  • How is the Rise of E-Commerce Changing the Role of Physical Stores? The rise of the internet has allowed retailers to directly connect with consumers from beyond the physical store revolutionising the competitive space more than ever. The world recently saw the acquisition of Amazon and Whole Foods which sent shock waves through the retail industry. This unforeseen merger has put retailers under pressure more than ever [...]...
  • SPX FLOW Appoints Pierre Sbabo as Vice President, Food and Beverage in EMEA SPX FLOW has announced the appointment of Pierre Sbabo as the Vice President of its Food and Beverage business in EMEA. He comes from a strong background in the water and process technology markets with truly international experience. With a Master’s Degree in Marketing and International Business from ESC Chambery, Sbabo has worked for global leaders [...]...

Extended use of Glavonoid™

Extended use of Glavonoid™
September 08
15:56 2015

Further approved fields of application enable new products to be launched

 Brussels (Belgium), September 2015Kaneka Pharma Europe, developer and patent holder of the liquorice root extract Glavonoid™, has successfully secured extended use approval for the novel food ingredient from the European Commission. Glavonoid™ offers unique support in reducing visceral fat. Besides being used in food supplements and beverages based on milk, yoghurt, fruit and vegetables, as accredited by its Novel Food status since 2011, Glavonoid can now also be applied in foods intended for medical purposes and energy-restricted diets for weight reduction.  

In DNA microarray analysis, Glavonoid™ has been shown to exhibit a two-way efficiency mechanism: On the one hand, it increases the body’s own fat burning ability by up-regulating genes involved in fatty acid oxidation, and on the other, it decreases fat development by down-regulating genes that are involved in fatty acid synthesis. Besides lowering body weight and BMI (body mass index), Glavonoid™ may also optimize cholesterol and blood glucose levels[1]. Derived from liquorice root (Glycyrrhiza glabra L.) via an advanced patented process, Glavonoid™ is 100 per cent free from glycyrrhizinic acid and contains 30 per cent liquorice glabra polyphenols. The allowed daily dose is 120 mg for adults.

Peter Lambrechts, Business Development Manager at Kaneka’s Quality of Life Division, who successfully guided the approval process, states: “With visceral fat being the main risk factor for the development of metabolic syndromes and other chronic diseases such as cardiovascular illnesses, we see extremely promising market potential here. The new regulatory status for Glavonoid™ paves the way for manufacturers to create new products targeting markets such as weight management and body shaping.

Glavonoid™ can be used in supplements as a single ingredient or as part of a multi-component system. It can also be included in products aimed at the sports and fitness market, as well as healthy ageing.

[1]Tominaga, Y. et al.: Obesity Research & Clinical Practice (2009) 3, 169-178

About Author

admin

admin

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • September 11, 2017drinktec
  • September 13, 2017FI Asia
  • September 19, 2017PROCESS EXPO 2017
  • September 22, 2017Global Summit on Food & Beverages
AEC v1.0.4

The Magazine

F&D Business Preferred Suppliers

Advertisements